Mikael Dolsten - 09 Sep 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Mikael Dolsten
Issuer symbol
RCKT
Transactions as of
09 Sep 2024
Transactions value $
$0
Form type
4
Filing time
11 Sep 2024, 16:07:06 UTC
Previous filing
11 Sep 2024
Next filing
16 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +27,545 $0 27,545 09 Sep 2024 Common Stock 27,545 $19.73 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $0 +22,988 $0 22,988 09 Sep 2024 Common Stock 22,988 $19.73 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 27,545 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on September 9, 2027.
F2 This option represents a right to purchase a total of 22,988 shares of the Issuer's common stock, which will fully vest on September 9, 2025.